Picture of Axim Biotechnologies logo

AXIM — Axim Biotechnologies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Axim Biotechnologies Unveils Covid-19 Rapid Diagnostic Test For Neutralizing Antibodies

July 15 (Reuters) - Axim Biotechnologies Inc  AXIM.PK :
    * AXIM® BIOTECHNOLOGIES UNVEILS FIRST–IN-CLASS COVID-19
RAPID
DIAGNOSTIC TEST FOR NEUTRALIZING ANTIBODIES AND FILES
PRE-EMERGENCY USE AUTHORIZATION WITH THE FDA

Source text for Eikon:  ID:nGNXb757Y6 
Further company coverage:  AXIM.PK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Axim Biotechnologies

See all news